References

National Institute for Health and Clinical Excellence. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents. March 2013. www.nice.org.uk

Scotish intercollegiate guidelines network (SIGN). Management of attention deficit and hyerpkinetic disorders in children and young people: A national clinical guideline. Guideline 112 October 2009.www.sign.ac.uk.

Nutt DJ, et al. Evidence-based guidelines for management of attention-deficit/ hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2007;21(1): 10-41.

Hints and tips

References

ADHD is an abbreviation for Attention Deficit Hyperactivity Disorder. The information provided on this website is not a substitute for professional medical care. As always if you have any concerns about you or your child’s health or medication you should consult your specialist or general practitioner. This site is published by Janssen-Cilag Limited, which is solely responsible for the content. It is intended for a UK audience.